New 5-Unsubstituted Dihydropyridines with Improved CaV1.3 Selectivity as Potential Neuroprotective Agents against Ischemic Injury-Reference-Cited by-同舟云学术

New 5-Unsubstituted Dihydropyridines with Improved CaV1.3 Selectivity as Potential Neuroprotective Agents against Ischemic Injury

Published:2014-05-07 Issue:10 Volume:57 Page:4313-4323
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Tenti Giammarco¹,Parada Esther²,León Rafael²³,Egea Javier²,Martínez-Revelles Sonia⁴,Briones Ana María⁴,Sridharan Vellaisamy¹⁵,López Manuela G.²³⁴,Ramos María Teresa¹,Menéndez J. Carlos¹

Affiliation:

1. Departamento de Química Orgánica y Farmacéutica, Facultad de Farmacia, Universidad Complutense, 28040 Madrid, Spain

2. Instituto Teófilo Hernando y Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, 28029 Madrid, Spain

3. Instituto de Investigación Sanitaria, Servicio de Farmacología Clínica, Hospital Universitario de la Princesa, 28006 Madrid, Spain

4. Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, Instituto de Investigación del Hospital Universitario La Paz (IdiPAZ), 28029 Madrid, Spain

5. Department of Chemistry, School of Chemical and Biotechnology, SASTRA University, Thanjavur 613401, Tamil Nadu, India

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm500263v

Reference60 articles.

1. Advances in stroke therapy

2. General aspects of neurodegeneration

3. Calcium, ischemia and excitotoxicity

4. Neuroprotection in acute ischemic stroke - current status

5. Voltage-gated cation channel modulators for the treatment of stroke

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calcium channel blockers’ contribution to overcoming Current drug discovery challenges in Alzheimer’s disease;Expert Opinion on Drug Discovery;2023-10-06

2. Enantioselective Catalytic Hantzsch Dihydropyridine Synthesis;ACS Catalysis;2023-05-01

3. Ca_v1.3‐selective inhibitors of voltage‐gated L‐type Ca²⁺ channels: Fact or (still) fiction?;British Journal of Pharmacology;2023-03-14

4. Usage of L-type calcium channel blockers to suppress drug reward and memory driving addiction: Past, present, and future;Neuropharmacology;2022-12

5. Multicomponent reactions as a privileged tool for multitarget-directed ligand strategies in Alzheimer’s disease therapy;Future Medicinal Chemistry;2022-11